Can China Innovate? Degron Aims For First-In-Class TPD Therapies

New Funds For Novel Platform

original innovation
Degron one of the latest Chinese biotechs devoted to developing innovative drugs • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from China

More from Focus On Asia